how Hyperbaric therapy can help 

HBOT has been shown in some studies to: Improve Brain Functioning & Performance, Improve Brain Repair Recovery, Attenuate Nervous System Inflammation, Increase Regeneration of the Nervous System, Improve Neurological Conditions.

Approximately 1 billion people, of all ages, are currently affected by neurological disorders, with an estimated 6.8 million related deaths that occur every year world-wide. This staggering statistical evidence illustrates the substantial impact of neurological disorders. New evidence presents how hyperbaric oxygen therapy (HBOT) is helping individuals regain neurological activity and functionality. For neuro-developmental and neuro-degenerative disorders, in addition to neurological injuries, HBOT provides the brain with increased levels of oxygen to help recover/repair brain tissue, increase neuronal stem cell growth and improve cognitive functioning. 

Clinical studies have demonstrated the benefits of HBOT for neurological conditions with the following:

Improve Brain Functioning & Performance

  • Increases Circulatory Pathways in the Brain
  • Enhance Memory and Mental Performance
  • Improves Oxygenation to the Brain

Improve Brain Repair & Recovery

  • Recovers and repairs damaged brain tissue
  • Develops and regains cognitive/motor functions

Attenuate Neuro-inflammation

  • Reduces cerebral edema, decreases intracranial pressure
  • Reduces cerebral infarction
  • Reduces blood-brain barrier breakdown
  • Minimizes oxidative stress

Increase Regeneration of the Nervous System 

  • Stimulates the Creation of New Brain Cells
  • Facilitates the Formation of New Brain Connections
  • Promotes the Construction of New Brain Tissue

Ameliorate Neurological Conditions

  • Neuro-developmental conditions (autism, cerebral palsy, fetal alcohol syndrome)
  • Neurodegenerative conditions (alzheimer’s, parkinson’s, huntington’s disease)
  • Neurological injuries (stroke, traumatic brain and spinal cord injuries, concussions)


Brain Function Improves with HBOT

A prospective, randomized, crossover, controlled trial was published in 2013 testing the effectiveness of HBOT for improving brain function and quality of life for mild-traumatic brain injured (mTBI) patients suffering chronic neurocognitive impairments. A total of 56 mTBI patients, 1-5 years after injury, with prolonged post-concussion syndrome were evaluated. Patients in the treated group were assessed at baseline and after 40 HBOT sessions. Whereas patients in the crossover group were evaluated three times: at baseline, after a two-month control period of no HBOT and after two months of 40 HBOT sessions. Significant improvements were confirmed in cognitive function and quality of life in both groups after HBOT; however, no significant improvement was observed following the control period. HBOT was shown to induce significant brain function improvements, neuroplasticity and increased brain activity according to SPECT imaging.


The information presented on this website is not intended as a basis for diagnosis or treatment and does not constitute a medical recommendation for individual health conditions. Content should also not be considered a substitute for care under a licensed medical professional. OBISPO HYPERBARIC supports the FDA for your full informed consent.

Start HEALING today!